Upregulation of Monocyte/Macrophage HGFIN (Gpnmb/Osteoactivin) Expression in End-Stage Renal Disease

Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mine...

Full description

Saved in:
Bibliographic Details
Published inClinical journal of the American Society of Nephrology Vol. 5; no. 1; pp. 56 - 61
Main Authors Pahl, Madeleine V., Vaziri, Nosratola D., Yuan, Jun, Adler, Sharon G.
Format Journal Article
LanguageEnglish
Published United States American Society of Nephrology 01.01.2010
SeriesOriginal Articles
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification. We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects. Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function. Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification.
AbstractList Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification.BACKGROUND AND OBJECTIVESHematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification.We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects.DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTSWe explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects.Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function.RESULTSDialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function.Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification.CONCLUSIONSUremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification.
Background and objectives: Hematopoietic growth factor–inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification. Design, setting, participants, & measurements: We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects. Results: Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function. Conclusions: Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification.
Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification. We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects. Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function. Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification.
Author Jun Yuan
Nosratola D. Vaziri
Sharon G. Adler
Madeleine V. Pahl
Author_xml – sequence: 1
  givenname: Madeleine V.
  surname: Pahl
  fullname: Pahl, Madeleine V.
– sequence: 2
  givenname: Nosratola D.
  surname: Vaziri
  fullname: Vaziri, Nosratola D.
– sequence: 3
  givenname: Jun
  surname: Yuan
  fullname: Yuan, Jun
– sequence: 4
  givenname: Sharon G.
  surname: Adler
  fullname: Adler, Sharon G.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19833906$$D View this record in MEDLINE/PubMed
BookMark eNptkUtv1DAUhS3Uij5gxxplgwCJdPyInWRTCQ3TaVEfUqESO8txbmZcOXaIPYX-ezyddgSoK9vy-c69OucA7TjvAKE3BB9RSvhk-vXyCDNWY47rF2ifcM7z9Pixs70XZA8dhHCLcVEwyl-iPVJXa0Lso_ZmGGGxsioa7zLfZRfeeX0fYXKh9OiHpVpAdjo_ObvMPswH1zeTqxDBKx3NnXEfs9nvxIewho3LZq7Nv8U1cg1O2eyLCaACvEK7nbIBXj-eh-jmZPZ9epqfX83Ppp_Pc12UdcwV0YrxCigrFYiu7YqyKnQH0HSsapuGtR2IlqoKsChVWXPRNpwnomyKktSUHaLjje-wanpoNbg4KiuH0fRqvJdeGfnvjzNLufB3klaYCE6SwftHg9H_XEGIsjdBg7XKgV8FWTImCK0ES8q3f4_aznhKNgnoRpBSDGGETmoTH1JOk42VBMt1fTLVJ5_qS9Cn_6Ct7_Pydxv50iyWv8wIMvTK2rQSlfpWBcclkVywP52cqbI
CitedBy_id crossref_primary_10_1186_s12967_023_04455_2
crossref_primary_10_1200_JCO_2013_54_8115
crossref_primary_10_1016_j_vetimm_2012_11_009
crossref_primary_10_4161_onci_20249
crossref_primary_10_1089_mab_2013_0005
crossref_primary_10_1016_j_ejphar_2022_175219
crossref_primary_10_1053_j_jrn_2011_10_020
crossref_primary_10_3390_cells10102703
crossref_primary_10_1016_j_trsl_2022_12_004
crossref_primary_10_1371_journal_pone_0035280
crossref_primary_10_1016_j_pharmthera_2017_05_010
crossref_primary_10_1016_j_lfs_2014_11_011
crossref_primary_10_1002_acr_24728
crossref_primary_10_1096_fj_202000651
crossref_primary_10_1186_1471_2164_15_965
crossref_primary_10_1007_s12031_014_0280_0
crossref_primary_10_4049_jimmunol_1103031
crossref_primary_10_1016_j_bbrc_2018_02_035
crossref_primary_10_3390_ijms20010066
crossref_primary_10_4049_jimmunol_1000413
crossref_primary_10_3389_fimmu_2021_674739
crossref_primary_10_1097_MED_0b013e328341311d
crossref_primary_10_1016_j_bbrc_2024_150386
crossref_primary_10_1111_cas_12601
crossref_primary_10_1093_ndt_gfx255
crossref_primary_10_1038_nrneph_2010_157
crossref_primary_10_1111_exd_13524
crossref_primary_10_1016_j_tice_2021_101683
crossref_primary_10_1053_j_ackd_2011_12_001
crossref_primary_10_1002_brb3_39
crossref_primary_10_1038_nrneph_2013_44
crossref_primary_10_1111_jorc_12231
crossref_primary_10_1096_fj_201600613R
crossref_primary_10_1186_1471_2164_11_532
crossref_primary_10_1016_j_cellimm_2017_03_006
crossref_primary_10_1371_journal_pone_0012093
crossref_primary_10_1007_s12035_017_0707_z
Cites_doi 10.1172/JCI116391
10.1016/S1567-133X(02)00012-1
10.1615/CritRevEukaryotGeneExpr.v13.i24.180
10.2174/157016108783955374
10.1097/01.ASN.0000129337.50739.48
10.1615/CritRevEukaryotGeneExpr.v13.i24.130
10.1517/13543784.17.4.451
10.1097/01.mnh.0000168336.67499.c0
10.4049/jimmunol.179.9.5778
10.1002/ijc.2910600111
10.1016/j.trsl.2007.12.005
10.4049/jimmunol.178.10.6557
10.1182/blood-2006-11-053769
10.1089/jir.2005.25.227
10.1016/j.jhep.2004.12.021
10.1016/j.semnephrol.2004.06.026
10.1093/ndt/gfn486
10.1093/nar/29.9.e45
10.1681/ASN.2006121367
10.1074/jbc.M008539200
10.1002/jcp.20841
10.1074/jbc.M203171200
10.1681/ASN.2006080926
10.1093/ndt/gfn571
10.1002/jcb.1259
10.2215/CJN.03850907
10.1161/hy1001.096358
10.1016/S0167-0115(02)00288-4
ContentType Journal Article
Copyright Copyright © 2010 by the American Society of Nephrology
Copyright_xml – notice: Copyright © 2010 by the American Society of Nephrology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.2215/CJN.03390509
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1555-905X
EndPage 61
ExternalDocumentID PMC2801651
19833906
10_2215_CJN_03390509
cjasn5_1_56
Genre Journal Article
GroupedDBID -
0R
29B
2WC
53G
5GY
5VS
AAWTL
ADACO
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
EBS
EJD
F5P
FH7
GX1
H13
HYE
HZ
KQ8
O9-
OK1
P2P
RHF
RHI
RPM
TNP
WOQ
ZA5
---
0R~
6PF
AAOCO
AAQQT
AAUIN
AAYXX
ABBLC
ABJNI
ABXYN
ACLDA
ACZKN
AFEXH
AFNMH
AHOMT
AHQVU
BTFSW
BYPQX
CITATION
ERAAH
HZ~
OVD
TEORI
TR2
W8F
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c479t-a1ca358e237ae6fdf4784cfeebf38dbb3dfe6d2a8e067a7956db553587b471923
ISSN 1555-9041
1555-905X
IngestDate Thu Aug 21 14:12:42 EDT 2025
Fri Jul 11 12:25:51 EDT 2025
Mon Jul 21 06:00:37 EDT 2025
Thu Apr 24 23:03:35 EDT 2025
Tue Jul 01 01:57:03 EDT 2025
Tue Jan 05 20:17:17 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c479t-a1ca358e237ae6fdf4784cfeebf38dbb3dfe6d2a8e067a7956db553587b471923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://cjasn.asnjournals.org/content/clinjasn/5/1/56.full.pdf
PMID 19833906
PQID 733612863
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2801651
proquest_miscellaneous_733612863
pubmed_primary_19833906
crossref_citationtrail_10_2215_CJN_03390509
crossref_primary_10_2215_CJN_03390509
highwire_smallpub2_cjasn5_1_56
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20100101
2010-01-00
2010-Jan
PublicationDateYYYYMMDD 2010-01-01
PublicationDate_xml – month: 01
  year: 2010
  text: 20100101
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationSeriesTitle Original Articles
PublicationTitle Clinical journal of the American Society of Nephrology
PublicationTitleAlternate Clin J Am Soc Nephrol
PublicationYear 2010
Publisher American Society of Nephrology
Publisher_xml – name: American Society of Nephrology
References Selim (R6-10-20230601) 2003; 13
Haralanova-Ilieva (R2-10-20230601) 2005; 42
Bostrom (R28-10-20230601) 1993; 91
Chung (R13-10-20230601) 2007; 109
Bandari (R4-10-20230601) 2003; 111
Bachner (R5-10-20230601) 2002; 1
Owen (R7-10-20230601) 2003; 13
Jofre (R22-10-20230601) 2006; 17
Chung (R14-10-20230601) 2007; 179
Efstratiadis (R15-10-20230601) 2008; 6
Kovesdy (R16-10-20230601) 2008; 17
Kovesdy (R17-10-20230601) 2008; 3
Porazko (R24-10-20230601) 2008; 24
Shikano (R3-10-20230601) 2001; 271
Abdelmagid (R10-10-20230601) 2007; 210
Hadjiargyrou (R11-10-20230601) 2002; 277
Al-Aly (R25-10-20230601) 2008; 151
Ripoll (R12-10-20230601) 2007; 178
Pfaffl (R21-10-20230601) 2001; 29
London (R27-10-20230601) 2004; 15
Weterman (R8-10-20230601) 1995; 60
London (R26-10-20230601) 2005; 14
Safadi (R1-10-20230601) 2001; 84
Jean (R23-10-20230601) 2008; 24
Towler (R29-10-20230601) 2007; 18
Vaziri (R20-10-20230601) 2004; 24
Nomiyama (R9-10-20230601) 2005; 25
Blacher (R18-10-20230601) 2001; 38
Foley (R19-10-20230601) 1998; 9
11641313 - Hypertension. 2001 Oct;38(4):938-42
7814155 - Int J Cancer. 1995 Jan 3;60(1):73-81
14696968 - Crit Rev Eukaryot Gene Expr. 2003;13(2-4):205-20
15213285 - J Am Soc Nephrol. 2004 Jul;15(7):1943-51
11328886 - Nucleic Acids Res. 2001 May 1;29(9):e45
11114299 - J Biol Chem. 2001 Mar 16;276(11):8125-34
18363512 - Expert Opin Investig Drugs. 2008 Apr;17(4):451-67
15812249 - J Interferon Cytokine Res. 2005 Apr;25(4):227-31
15763343 - J Hepatol. 2005 Apr;42(4):565-72
12638126 - Brain Res Gene Expr Patterns. 2002 Oct;1(3-4):159-65
18393910 - Curr Vasc Pharmacol. 2008 Apr;6(2):93-107
17259596 - J Am Soc Nephrol. 2007 Feb;18(2):369-73
11443763 - J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S16-23
12609765 - Regul Pept. 2003 Mar 28;111(1-3):169-78
17130274 - J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S274-80
12055193 - J Biol Chem. 2002 Aug 16;277(33):30177-82
17284525 - Blood. 2007 May 15;109(10):4320-7
18433704 - Transl Res. 2008 May;151(5):233-9
17034042 - J Cell Physiol. 2007 Jan;210(1):26-37
16205470 - Curr Opin Nephrol Hypertens. 2005 Nov;14(6):525-31
15490413 - Semin Nephrol. 2004 Sep;24(5):469-73
14696973 - Crit Rev Eukaryot Gene Expr. 2003;13(2-4):265-75
18045858 - Clin J Am Soc Nephrol. 2008 Jan;3(1):168-73
17947650 - J Immunol. 2007 Nov 1;179(9):5778-84
18775894 - Nephrol Dial Transplant. 2009 Feb;24(2):589-96
8473518 - J Clin Invest. 1993 Apr;91(4):1800-9
11746512 - J Cell Biochem. 2001;84(1):12-26
17475886 - J Immunol. 2007 May 15;178(10):6557-66
18852190 - Nephrol Dial Transplant. 2009 Mar;24(3):948-55
References_xml – volume: 91
  start-page: 1800
  year: 1993
  ident: R28-10-20230601
  article-title: Bone morphogenic protein expression in human atherosclerotic lesions
  publication-title: J Clin Invest
  doi: 10.1172/JCI116391
– volume: 1
  start-page: 159
  year: 2002
  ident: R5-10-20230601
  article-title: mRNA expression of the murine glycoprotein (transmembrane) nmb (Gpnmb) gene is linked to the developing retinal pigment epithelium and iris
  publication-title: Brain Res Gene Expr Patterns
  doi: 10.1016/S1567-133X(02)00012-1
– volume: 13
  start-page: 265
  year: 2003
  ident: R6-10-20230601
  article-title: Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro
  publication-title: Crit Rev Eukaryot Gene Expr
  doi: 10.1615/CritRevEukaryotGeneExpr.v13.i24.180
– volume: 6
  start-page: 93
  year: 2008
  ident: R15-10-20230601
  article-title: Atherogenesis in renal patients: A model of vascular disease?
  publication-title: Curr Vasc Pharmacol
  doi: 10.2174/157016108783955374
– volume: 15
  start-page: 1943
  year: 2004
  ident: R27-10-20230601
  article-title: Arterial calcifications and bone histomorphometry in end-stage renal disease
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000129337.50739.48
– volume: 13
  start-page: 205
  year: 2003
  ident: R7-10-20230601
  article-title: Identification and characterization of the genes encoding human and mouse osteoactivin
  publication-title: Crit Rev Eukaryot Gene Expr
  doi: 10.1615/CritRevEukaryotGeneExpr.v13.i24.130
– volume: 17
  start-page: 451
  year: 2008
  ident: R16-10-20230601
  article-title: Novel targets and new potential: Developments in the treatment of inflammation in chronic kidney disease
  publication-title: Expert Opin Investig Drugs
  doi: 10.1517/13543784.17.4.451
– volume: 14
  start-page: 525
  year: 2005
  ident: R26-10-20230601
  article-title: Arteriosclerosis, vascular calcifications, and cardiovascular disease in uremia
  publication-title: Curr Opin Nephrol Hypertens
  doi: 10.1097/01.mnh.0000168336.67499.c0
– volume: 179
  start-page: 5778
  year: 2007
  ident: R14-10-20230601
  article-title: Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.179.9.5778
– volume: 60
  start-page: 73
  year: 1995
  ident: R8-10-20230601
  article-title: nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts
  publication-title: Int J Cancer
  doi: 10.1002/ijc.2910600111
– volume: 151
  start-page: 233
  year: 2008
  ident: R25-10-20230601
  article-title: Arterial calcification: A tumor necrosis factor-alpha mediated vascular Wnt-opathy
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2007.12.005
– volume: 178
  start-page: 6557
  year: 2007
  ident: R12-10-20230601
  article-title: GPNMB is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses
  publication-title: J Immunol
  doi: 10.4049/jimmunol.178.10.6557
– volume: 109
  start-page: 4320
  year: 2007
  ident: R13-10-20230601
  article-title: DC-HIL is a negative regulator of T lymphocyte activation
  publication-title: Blood
  doi: 10.1182/blood-2006-11-053769
– volume: 25
  start-page: 227
  year: 2005
  ident: R9-10-20230601
  article-title: Identification of genes differentially expressed in osteoclast-like cells
  publication-title: J Interferon Cytokine Res
  doi: 10.1089/jir.2005.25.227
– volume: 42
  start-page: 565
  year: 2005
  ident: R2-10-20230601
  article-title: Expression of osteoactivin in rat and human liver and isolated rat liver cells
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2004.12.021
– volume: 24
  start-page: 469
  year: 2004
  ident: R20-10-20230601
  article-title: Oxidative stress in chronic renal failure: The nature, mechanism and consequences
  publication-title: Semin Nephrol
  doi: 10.1016/j.semnephrol.2004.06.026
– volume: 24
  start-page: 589
  year: 2008
  ident: R24-10-20230601
  article-title: IL-18 is involved in vascular injury in end-stage renal disease patients
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfn486
– volume: 29
  start-page: e45
  year: 2001
  ident: R21-10-20230601
  article-title: A new mathematical model for relative quantification in real-time RT-PCR
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/29.9.e45
– volume: 18
  start-page: 369
  year: 2007
  ident: R29-10-20230601
  article-title: Calciotropic hormones and arterial physiology: “D”-lightful insights
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2006121367
– volume: 271
  start-page: 8125
  year: 2001
  ident: R3-10-20230601
  article-title: Molecular cloning of dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparin sulfate
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M008539200
– volume: 210
  start-page: 26
  year: 2007
  ident: R10-10-20230601
  article-title: Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.20841
– volume: 277
  start-page: 30177
  year: 2002
  ident: R11-10-20230601
  article-title: Transcriptional profiling of bone regeneration: Insight into the molecular complexity of wound repair
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M203171200
– volume: 17
  start-page: S274
  year: 2006
  ident: R22-10-20230601
  article-title: Inflammatory syndrome in patients on hemodialysis
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2006080926
– volume: 24
  start-page: 948
  year: 2008
  ident: R23-10-20230601
  article-title: Peripheral vascular calcification in long-haemodialysis patients: Associated factors and survival consequences
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfn571
– volume: 84
  start-page: 12
  year: 2001
  ident: R1-10-20230601
  article-title: Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.1259
– volume: 3
  start-page: 168
  year: 2008
  ident: R17-10-20230601
  article-title: Battleground: Chronic kidney disorders mineral and bone disease—Calcium obsession, vitamin D, and binder confusion
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.03850907
– volume: 38
  start-page: 938
  year: 2001
  ident: R18-10-20230601
  article-title: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
  publication-title: Hypertension
  doi: 10.1161/hy1001.096358
– volume: 111
  start-page: 169
  year: 2003
  ident: R4-10-20230601
  article-title: Hematopoietic growth factor inducible neurokinin-1 (HGFIN) gene: A transmembrane protein that is similar to neurokinin-1 interacts with substance
  publication-title: Regul Pept
  doi: 10.1016/S0167-0115(02)00288-4
– volume: 9
  start-page: S16
  year: 1998
  ident: R19-10-20230601
  article-title: Epidemiology of cardiovascular disease in chronic renal disease
  publication-title: J Am Soc Nephrol
– reference: 18363512 - Expert Opin Investig Drugs. 2008 Apr;17(4):451-67
– reference: 15213285 - J Am Soc Nephrol. 2004 Jul;15(7):1943-51
– reference: 18045858 - Clin J Am Soc Nephrol. 2008 Jan;3(1):168-73
– reference: 11443763 - J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S16-23
– reference: 17475886 - J Immunol. 2007 May 15;178(10):6557-66
– reference: 15763343 - J Hepatol. 2005 Apr;42(4):565-72
– reference: 17034042 - J Cell Physiol. 2007 Jan;210(1):26-37
– reference: 18433704 - Transl Res. 2008 May;151(5):233-9
– reference: 8473518 - J Clin Invest. 1993 Apr;91(4):1800-9
– reference: 14696968 - Crit Rev Eukaryot Gene Expr. 2003;13(2-4):205-20
– reference: 7814155 - Int J Cancer. 1995 Jan 3;60(1):73-81
– reference: 11746512 - J Cell Biochem. 2001;84(1):12-26
– reference: 18775894 - Nephrol Dial Transplant. 2009 Feb;24(2):589-96
– reference: 17259596 - J Am Soc Nephrol. 2007 Feb;18(2):369-73
– reference: 11641313 - Hypertension. 2001 Oct;38(4):938-42
– reference: 18393910 - Curr Vasc Pharmacol. 2008 Apr;6(2):93-107
– reference: 12055193 - J Biol Chem. 2002 Aug 16;277(33):30177-82
– reference: 14696973 - Crit Rev Eukaryot Gene Expr. 2003;13(2-4):265-75
– reference: 11328886 - Nucleic Acids Res. 2001 May 1;29(9):e45
– reference: 16205470 - Curr Opin Nephrol Hypertens. 2005 Nov;14(6):525-31
– reference: 15812249 - J Interferon Cytokine Res. 2005 Apr;25(4):227-31
– reference: 17947650 - J Immunol. 2007 Nov 1;179(9):5778-84
– reference: 17130274 - J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S274-80
– reference: 17284525 - Blood. 2007 May 15;109(10):4320-7
– reference: 18852190 - Nephrol Dial Transplant. 2009 Mar;24(3):948-55
– reference: 12638126 - Brain Res Gene Expr Patterns. 2002 Oct;1(3-4):159-65
– reference: 12609765 - Regul Pept. 2003 Mar 28;111(1-3):169-78
– reference: 15490413 - Semin Nephrol. 2004 Sep;24(5):469-73
– reference: 11114299 - J Biol Chem. 2001 Mar 16;276(11):8125-34
SSID ssj0044325
Score 2.159727
Snippet Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous...
Background and objectives: Hematopoietic growth factor–inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein...
SourceID pubmedcentral
proquest
pubmed
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 56
SubjectTerms Cells, Cultured
Humans
Kidney Failure, Chronic - metabolism
Macrophages - metabolism
Membrane Glycoproteins
Membrane Proteins - biosynthesis
Middle Aged
Monocytes - metabolism
Original
Up-Regulation
Title Upregulation of Monocyte/Macrophage HGFIN (Gpnmb/Osteoactivin) Expression in End-Stage Renal Disease
URI http://cjasn.asnjournals.org/content/5/1/56.abstract
https://www.ncbi.nlm.nih.gov/pubmed/19833906
https://www.proquest.com/docview/733612863
https://pubmed.ncbi.nlm.nih.gov/PMC2801651
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiDflsfIBJFCVtImd1xEtLWWllst2VU6REzvbotap-kCwP5VfwzjOwy1FC1yiKnYbp98Xe8aZ-Qah11xwwkMntcKIU4uKiFhh6jArTQmlIuE-EyrfeTT2hxN6PvWmrdZPI2ppt03s9PpoXsn_oArnAFeVJfsPyNY_CifgM-ALR0AYjn-F8WS11qXkS6sPHtA8_aEK3g1GTNXmmqmInOHHwadxsR2wkssE2j4DsrlKaPimdwX638to2CLqsS-5BSbolSroIItJsXmFU0kaVOmUhu6EkaIi61hQtR0hgC57e_cjpUwplHV7aYMFO6tjPMb5Rr30X7DOB7tzya7n63kd4LOTnS-7hslKZ1rpgdgdFWiwNvcuihC4vTiQm0dVzsqeZ0U9rZBlC_OcNzWncu83xuppWWuXH64WrhbWODsf2z1CIqWEY3YDrFfLgjlOFKr2I5LdB0tpHeCYfmUb6cVO7Pm30G0XXBi32knSVgKlpCgIXN-aTspQQ-qaAypEbfXV9y2nSs36mGd0GOBrWEwX99G90tXB7zVvH6CWkA_RnVEZzPEIcZO-OM9wRd9uQ15ckBe_LajbNYn7Dje0xXOJa9rigra4pO1jNBn0L86GVln0w0ppEG0t5qSMeKFwScCEn_GMBiFNMyGSjIQ8SQjPhM9dFgqws1gA7j1PPA--ESRgZ4G78gSdyFyKZwg7sBrDmpVRQQkFPzsiqnKh2wMLOvMz4rVRp_pD47RUxFeFWRYxeMYKiRiQiCsk2uhN3XullWD-0O-0wibeLNliAVC4sUGINsIVYjHM5eoFHZMi321iJU0K9qJP2uipBrC5UkmCNgr2oK07KJn4_RY5nxVy8W6oUhad5zeN6wW62zyjL9HJdr0Tr8Di3ianBXV_ARjs2ew
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Upregulation+of+Monocyte%2FMacrophage+HGFIN+%28Gpnmb%2FOsteoactivin%29+Expression+in+End-Stage+Renal+Disease&rft.jtitle=Clinical+journal+of+the+American+Society+of+Nephrology&rft.au=Madeleine+V.+Pahl&rft.au=Nosratola+D.+Vaziri&rft.au=Jun+Yuan&rft.au=Sharon+G.+Adler&rft.date=2010-01-01&rft.pub=American+Society+of+Nephrology&rft.issn=1555-9041&rft.eissn=1555-905X&rft.volume=5&rft.issue=1&rft.spage=56&rft_id=info:doi/10.2215%2FCJN.03390509&rft_id=info%3Apmid%2F19833906&rft.externalDBID=n%2Fa&rft.externalDocID=cjasn5_1_56
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1555-9041&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1555-9041&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1555-9041&client=summon